Role of IGF-1 and Estrogen in Skeletal Anabolic Response to Loading

IGF-1 和雌激素在骨骼合成代谢反应中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Title: IGF-I as a mediator of skeletal anabolic response to loading It is well known that the development of skeletal architecture and maintenance of bone mass are dependent on mechanical stimulation. Although gene expression studies have revealed evidence for the involvement of several potential candidate genes as mediators of mechanical loading (ML) response, direct evidence for the involvement of these genes in mediating bone anabolic response to ML is lacking. In terms of potential mediators of ML response in the skeleton, Insulin like growth factor-I (IGF-I) has received considerable attention since IGF-I expression has been shown to increase rapidly in response to mechanical strain in bones in vivo and bone cells in vitro and since transgenic studies involving disruption of IGF-I gene have shown that IGF-I is a key bone formation regulator. Based on past findings and our preliminary data, we propose the hypothesis that ML induced increase in IGF-I expression interacts with estrogen to determine the amount of new bone formed in response to mechanical strain. To evaluate this hypothesis, we have proposed cause and effect relationship studies between IGF-I, estrogen and bone formation response to ML utilizing IGF-I conditional knockout (KO) mice in which IGF-I gene is disrupted using Cre/LoxP approach. We will generate IGF-I KO mice by crossing loxP IGF-I mice with transgenic Cre mice in which Cre expression is driven by promoter and enhancer elements of alpha2 chain of type I collagen promoter. ML will be induced by four-point bending in the tibia or axial compression of forelimb. In vivo pQCT and Real time RT-PCR will be used to quantitate changes in bone parameters (loaded and non-loaded bones) and gene expression, respectively. Three-point bending and micro-CT will be used to measure changes in the mechanical properties, and architecture in response to loading in both the KO and the control mice. Histology will be carried out using calcein-double labeling in order to measure bone formation rate, osteoblast cell population, mineral apposition rate, and osteoblast activity resulting from ML. To determine if estrogen interacts with IGF-I to regulate skeletal anabolic response to loading, control and IGF-I conditional KO mice will be ovariectomized and skeletal response to ML determined. Our understanding of the role of IGF-I and estrogen in mediating bone formation response to loading will lead to development of strategies to increase bone anabolic response to ML by modulating local IGF-I actions in bone.
描述(由申请人提供): 标题:IGF-I作为负载骨骼合成代谢反应的介体,众所周知,骨骼结构的发展和骨骼质量的维持取决于机械刺激。尽管基因表达研究揭示了一些潜在候选基因作为机械载荷(ML)反应的介导子的证据,但缺乏这些基因参与介导骨合成代谢反应ML的直接证据。 In terms of potential mediators of ML response in the skeleton, Insulin like growth factor-I (IGF-I) has received considerable attention since IGF-I expression has been shown to increase rapidly in response to mechanical strain in bones in vivo and bone cells in vitro and since transgenic studies involving disruption of IGF-I gene have shown that IGF-I is a key bone formation regulator.根据过去的发现和我们的初步数据,我们提出了以下假设:ML诱导的IGF-I表达与雌激素相互作用,以确定响应机械应变而形成的新骨的量。为了评估这一假设,我们提出了IGF-I,雌激素和骨形成对ML的因果关系研究,利用IGF-I条件敲除(KO)小鼠,其中使用CRE/LOXP方法破坏IGF-I基因。我们将通过将LOXP IGF-I小鼠与转基因CRE小鼠跨越LOXP IGF-I小鼠产生IGF-I KO小鼠,其中CRE表达是由I型胶原蛋白启动子的α2链的启动子和增强子元素驱动的。 ML将通过胫骨或前肢的轴向压缩在四点弯曲中诱导。体内PQCT和实时RT-PCR将分别用于定量骨参数(负载和未加载的骨骼)和基因表达的变化。三分弯曲和Micro-CT将用于测量机械性能的变化,以及响应于KO和对照小鼠的负载的体系结构。组织学将使用钙软糖双重标记进行,以测量骨骼形成率,成骨细胞群,矿物质份含量和由ML产生的成骨细胞活性。为了确定雌激素是否与IGF-I相互作用以调节对加载的骨骼合成代谢反应,对照和IGF-I条件KO小鼠将进行Ovariectomictomized,并且对确定的ML的骨骼反应。我们对IGF-I和雌激素在介导骨形成对负载的反应中的作用的理解将导致发展通过调节骨骼中局部IGF-I的局部IGF-I作用来增加对ML的骨骼合成代谢反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chandrasekhar Kesavan其他文献

Chandrasekhar Kesavan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chandrasekhar Kesavan', 18)}}的其他基金

Role of IGF-1 and Estrogen in Skeletal Anabolic Response to Loading
IGF-1 和雌激素在骨骼合成代谢反应中的作用
  • 批准号:
    8136858
  • 财政年份:
    2011
  • 资助金额:
    $ 7.7万
  • 项目类别:
Role of IGF-1 and Estrogen in Skeletal Anabolic Response to Loading
IGF-1 和雌激素在骨骼合成代谢反应中的作用
  • 批准号:
    7910688
  • 财政年份:
    2009
  • 资助金额:
    $ 7.7万
  • 项目类别:

相似国自然基金

粪便mtDNA异质性特征及其在哺乳动物年龄估算中的意义
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
粪便mtDNA异质性特征及其在哺乳动物年龄估算中的意义
  • 批准号:
    32170517
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
EEDA在RPE细胞中的功能及其在年龄相关性视网膜病变中的机制研究
  • 批准号:
    81770946
  • 批准年份:
    2017
  • 资助金额:
    56.0 万元
  • 项目类别:
    面上项目
sFlt-1基因靶向敲除诱导鼠新生血管性眼底病及其机制的实验研究
  • 批准号:
    81271016
  • 批准年份:
    2012
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Robo4基因敲除诱导小鼠年龄相关性视网膜变性及机制研究
  • 批准号:
    81170853
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
  • 批准号:
    10751106
  • 财政年份:
    2024
  • 资助金额:
    $ 7.7万
  • 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
  • 批准号:
    10465010
  • 财政年份:
    2023
  • 资助金额:
    $ 7.7万
  • 项目类别:
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
  • 批准号:
    10556087
  • 财政年份:
    2023
  • 资助金额:
    $ 7.7万
  • 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
  • 批准号:
    10637981
  • 财政年份:
    2023
  • 资助金额:
    $ 7.7万
  • 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
  • 批准号:
    10638439
  • 财政年份:
    2023
  • 资助金额:
    $ 7.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了